These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15619044)

  • 1. Reduction of peritoneal membrane permeability by long-term use of neutral-pH peritoneal dialysis solution: a preliminary report in high transporters.
    Kuriyama S; Otsuka Y; Iida R; Kobayashi S; Yamagishi H; Hosoya T
    Clin Exp Nephrol; 2004 Dec; 8(4):392-3. PubMed ID: 15619044
    [No Abstract]   [Full Text] [Related]  

  • 2. What are the problems with using the peritoneal membrane for long-term dialysis?
    Bargman JM; Krediet RT; Lo WK; Selgas R; del Peso G; Auxiliadora Bajo M; Mujais S
    Semin Dial; 2008; 21(1):11-23. PubMed ID: 18251949
    [No Abstract]   [Full Text] [Related]  

  • 3. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid protects against the development of encapsulating peritoneal sclerosis on peritoneal dialysis.
    Imai H; Nakamoto H; Fucshima R; Yamanouchi Y; Ishida Y; Suzuki H
    Adv Perit Dial; 2002; 18():124-30. PubMed ID: 12402603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress induced by iron released from transferrin in low pH peritoneal dialysis solution.
    Yamaji Y; Nakazato Y; Oshima N; Hayashi M; Saruta T
    Nephrol Dial Transplant; 2004 Oct; 19(10):2592-7. PubMed ID: 15292463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of peritoneal membrane function--new insights.
    Smit W
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii16-9. PubMed ID: 16825253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes.
    Sritippayawan S; Chiangjong W; Semangoen T; Aiyasanon N; Jaetanawanitch P; Sinchaikul S; Chen ST; Vasuvattakul S; Thongboonkerd V
    J Proteome Res; 2007 Nov; 6(11):4356-62. PubMed ID: 17924681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of cytokines in peritoneal dialysis].
    Opatrná S; Topolcan O; Opatrný K
    Vnitr Lek; 2000 Nov; 46(11):794-800. PubMed ID: 15637896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New animal models for encapsulating peritoneal sclerosis--role of acidic solution.
    Nakamoto H; Imai H; Ishida Y; Yamanouchi Y; Inoue T; Okada H; Suzuki H
    Perit Dial Int; 2001; 21 Suppl 3():S349-53. PubMed ID: 11887851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resumption of peritoneal dialysis after transcutaneous treatment of a peritoneal leakage using fibrin glue.
    Herbrig K; Pistrosch F; Gross P; Palm C
    Nephrol Dial Transplant; 2006 Jul; 21(7):2037-8. PubMed ID: 16520352
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biocompatibility of dialysis fluid in peritoneal dialysis--limitations and possibilities of improvement].
    Olszowska A; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):364-7. PubMed ID: 18634375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is new in peritoneal dialysis in the years 2003-2004.
    Grzegorzewska AE
    Rocz Akad Med Bialymst; 2004; 49():170-3. PubMed ID: 15631336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern.
    Chung SH; Heimbürger O; Lindholm B
    Semin Dial; 2008; 21(1):7-10. PubMed ID: 18251948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal membrane structural and functional changes during peritoneal dialysis.
    Goffin E
    Semin Dial; 2008; 21(3):258-65. PubMed ID: 18363601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis.
    Sugiyama N; Tawada M; Sun T; Suzuki Y; Kinashi H; Yamaguchi M; Katsuno T; Aten J; Vlahu CA; van Kuppevelt TH; Takei Y; Ishimoto T; Maruyama S; Mizuno M; Ito Y
    Clin Exp Nephrol; 2021 Sep; 25(9):1035-1046. PubMed ID: 33999275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new neutral-pH low-GDP peritoneal dialysis fluid.
    Himmele R; Jensen L; Fenn D; Ho CH; Sawin DA; Diaz-Buxo JA
    Perit Dial Int; 2012; 32(4):444-52. PubMed ID: 22383632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucotoxicity in peritoneal dialysis--solutions for the solution!
    Holmes CJ
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):269-78. PubMed ID: 17603981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between dialysate oxidized protein and peritoneal membrane transport properties in patients on peritoneal dialysis.
    Latcha S; Hong S; Gibbons N; Kohn N; Mattana J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3295-301. PubMed ID: 18443211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.